Two cases of obese children with increased intracranial pressure were reported

doi:10.3877/cma.j.issn.2095-9605.2025.02.011

Abstract

Abstract:

The most common manifestations of increased intracranial pressure are headache and visual impairment, and obesity is an underrecognized risk factor for intracranial hypertension in children. This article introduces the diagnosis and treatment process of two obese children with intracranial hypertension, aiming to improve clinicians' understanding of the disease and early intervention in childhood obesity to reduce the occurrence of multiple complications and improve the quality of life.

Key words: Obesity, Intracranial hypertension, Children

Yue Zhao, Yong Liu, Juan Li, Meiling Huo. Two cases of obese children with increased intracranial pressure were reported[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2025, 11(02): 153-156.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfpydxbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9605.2025.02.011

https://zhfpydxbdzzz.cma-cmc.com.cn/EN/Y2025/V11/I02/153

Figures/Tables 1

References 18

[1]	Yiangou A, Mollan SP, Sinclair AJ. Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms [J]. Nat Rev Neurol, 2023, 19(12): 769-785.
[2]	Amin S, Monaghan M, Forrest K, et al. Consensus recommendations for the assessment and management of idiopathic intracranial hypertension in children and young people [J]. Arch Dis Child, 2024, 109(8): 654-658.
[3]	Thaller M, Mytton J, Wakerley BR, et al. Idiopathic intracranial hypertension: Evaluation of births and fertility through the Hospital Episode Statistics dataset [J]. BJOG, 2022, 129(12): 2019-2027.
[4]	Adderley NJ, Subramanian A, Nirantharakumar K, et al. Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom [J]. JAMA Neurol, 2019, 76(9): 1088-1098.
[5]	Mollan SP, Aguiar M, Evison F, et al. The expanding burden of idiopathic intracranial hypertension [J]. Eye (Lond), 2019, 33(3): 478-485.
[6]	Mollan SP, Mitchell JL, Yiangou A, et al. Association of Amount of Weight Lost After Bariatric Surgery With Intracranial Pressure in Women With Idiopathic Intracranial Hypertension [J]. Neurology, 2022, 99(11): e1090-e1099.
[7]	Westgate CS, Botfield HF, Alimajstorovic Z, et al. Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension [J]. JCI Insight, 2021, 6(10): e145346.
[8]	Yiangou A, Mitchell JL, Vijay V, et al. Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension [J]. J Headache Pain, 2020, 21(1): 116.
[9]	Vijay V, Mollan SP, Mitchell JL, et al. Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension [J]. JAMA Ophthalmol, 2020, 138(12): 1264-1271.
[10]	Mollan SP, Momin SNA, Khatkar PS, et al. A Neuro-Ophthalmologist's Guide to Advances in Intracranial Pressure Measurements [J]. Eye Brain, 2023, 15: 113-124.
[11]	Mollan SP, Davies B, Silver NC, et al. Idiopathic intracranial hypertension: consensus guidelines on management [J]. J Neurol Neurosurg Psychiatry, 2018, 89(10): 1088-1100.
[12]	Pascarella A, Manzo L, Bono F. Effect of mannitol bolus administration on cerebrospinal fluid pressure in patients with idiopathic intracranial hypertension: a pilot study. J [J]. Neurol, 2022, 269(11): 6158-6164.
[13]	Adderley NJ, Subramanian A, Perrins M, et al. Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study [J]. Neurology, 2022, 99(18): e1968-e1978.
[14]	Gurney SP, Ramalingam S, Thomas A, et al. Exploring the current management idiopathic intracranial hypertension, and understanding the role of dural venous sinus stenting [J]. Eye Brain, 2020, 12: 1-13.
[15]	Grech O, Mitchell JL, Lyons HS, et al. Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension [J]. Eye (Lond), 2024, 38(7): 1374-1379.
[16]	Apperley L, Kumar R, Senniappan S. Idiopathic intracranial hypertension in children with obesity [J]. Acta Paediatr, 2022, 111(7): 1420-1426.
[17]	Matthews Y, Dean F, Matyka K, et al. UK surveillance of childhood idiopathic intracranial hypertension (IIH) [J]. Arch Dis Child, 2012, 97(Suppl 1): A6-A.
[18]	Stiebel-Kalish H, Serov I, Sella R, et al. Childhood overweight or obesity increases the risk of IIH recurrence fivefold [J]. Int J Obes, 2014, 38(11): 1475-1477.

Please choose a citation manager

Content to export